Abstracts tagged "Polymyalgia rheumatica and ultrasound"

Abstract Number: 2770 • 2014 ACR/ARHP Annual Meeting
Polymyalgia Rheumatica Relapse and “Silence” Large Vessel Vasculitis. Is There Any Association?
Stavros Chrysidis¹, Philip Rask Lage-Hansen¹ and Andreas P. Diamantopoulos², ¹Department of Rheumatology, Hospital of Southwest Denmark, Esbjerg, Denmark, ²Rheumatology, Hospital of Southern Norway Trust, Kristiansand, Norway
Background/Purpose Large Vessel Vasculitis (LVV) can present with heterogeneous clinical manifestations, which range from general symptoms (fever, loss of weight) to the classic symptoms of …
Abstract Number: 120 • 2012 ACR/ARHP Annual Meeting
Evaluation of Joint Involvement in Patients Suffering From Early Polymyalgia Rheumatica Using High Resolution Ultrasound
Sandra Balser¹, Emmanuelle LeBras¹, Boris P. Ehrenstein², Martina Müller³, Martin Fleck² and Wolfgang Hartung², ¹Rheumatology & Clinical Immunology, Asklepios Klinikum Bad Abbach, Bad Abbach, Germany, ²Rheumatology & Clinical Immunology, Asklepios Clinic Bad Abbach, Bad Abbach, Germany, ³Clinic for Internal Medicine I, University Clinic Regensburg, Regensburg
Background/Purpose: The new EULAR/ACR 2012 classification criteria for polymyalgia rheumatica (PMR) are the first classification criteria that contain musculoskeletal ultrasound (MUS) in an additional algorithm…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].